Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227
一项针对原发性中枢神经系统淋巴瘤的I期和II期研究：采用甲氨蝶呤、利妥昔单抗和替莫唑胺进行诱导化疗，随后进行全脑放疗和放疗后替莫唑胺治疗：NRG肿瘤学RTOG 0227
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2015.64.8634
Glass, Jon; Won, Minhee; Schultz, Christopher J; Brat, Daniel; Bartlett, Nancy L; Suh, John H; Werner-Wasik, Maria; Fisher, Barbara Jean; Liepman, Marcia K; Augspurger, Mark; Bokstein, Felix; Bovi, Joseph A; Solhjem, Matthew C; Mehta, Minesh P
